These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 2554046)
1. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin]. Tsukamura M Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing]. Tsukamura M Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008 [TBL] [Abstract][Full Text] [Related]
3. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results]. Tsukamura M; Yamori S Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments]. Tsukamura M Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817 [TBL] [Abstract][Full Text] [Related]
5. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine]. Tsukamura M Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117 [TBL] [Abstract][Full Text] [Related]
6. [Cross-resistance relationship between streptomycin and kanamycin resistances in Mycobacterium smegmatis (strain Jucho)--comparison of the development patterns of resistances to streptomycin and kanamycin among Mycobacterium tuberculosis, Mycobacterium avium complex, and Mycobacterium smegmatis]. Tsukamura M Kekkaku; 1990 Dec; 65(12):785-9. PubMed ID: 2127614 [TBL] [Abstract][Full Text] [Related]
7. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM]. Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941 [TBL] [Abstract][Full Text] [Related]
8. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis. Yamada T; Mizuguchi Y; Suga K J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857 [No Abstract] [Full Text] [Related]
9. [Utility of the direct culture examination (Ziehl-Neelsen) using the Bactec system for the presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium xenopi, and Mycobacterium kansasii]. Moreno C; Garrigó M; Sánchez F; Coll P Enferm Infecc Microbiol Clin; 1994 May; 12(5):241-5. PubMed ID: 7811323 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of clinical efficacy of rifampicin in the treatment of nontuberculous mycobacteriosis from in vitro susceptibility testing]. Tsukamura M Kekkaku; 1989 Jul; 64(7):453-8. PubMed ID: 2585946 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria]. Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542 [TBL] [Abstract][Full Text] [Related]
12. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin]. Makarevich NM; Mkrtchian SV; Afanas'eva IuP Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321 [No Abstract] [Full Text] [Related]
13. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare]. Truffot-Pernot C; Giroir AM; Maury L; Grosset J Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531 [TBL] [Abstract][Full Text] [Related]
14. [Radiometric determination of Mycobacterium avium-intracellulare and Mycobacterium xenopi sensitivity to antitubercular agents]. Kubín M; Lindholm-Levy P; Heifets LB Epidemiol Mikrobiol Imunol; 1994 Sep; 43(3):104-6. PubMed ID: 7953081 [TBL] [Abstract][Full Text] [Related]
15. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis]. Tsukamura M; Toyama H; Mizuno S; Tsukamura S Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935 [No Abstract] [Full Text] [Related]
16. [Bactericidal activities of rifampicin, ethambutol, enviomycin and streptomycin on Mycobacterium avium-Mycobacterium intracellulare complex strains]. Tsukamura M; Yamori S Kekkaku; 1990 Aug; 65(8):519-25. PubMed ID: 2214513 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin. Selvakumar N; Kumar V; Acharyulu GS; Rehman F; Paramasivan CN; Prabhakar R Indian J Med Res; 1992 May; 95():101-4. PubMed ID: 1506058 [TBL] [Abstract][Full Text] [Related]
18. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis. Tsukamura M; Mizuno S J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402 [TBL] [Abstract][Full Text] [Related]
19. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs]. Nagata A; Mase M; Yamamoto M; Nakamura H Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767 [No Abstract] [Full Text] [Related]
20. Mycobacterium resistance to antimycobacterial reagent. Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L Therapie; 1999; 54(5):623-5. PubMed ID: 10667100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]